期刊文献+

Carpal tunnel syndrome diagnosis: validation of a clinic-based nerve conduction measurement device

Carpal tunnel syndrome diagnosis: validation of a clinic-based nerve conduction measurement device
下载PDF
导出
摘要 Background: Carpal Tunnel Syndrome (CTS) is the commonest upper limb nerve entrapment syndrome seen in practice. In many centres, nerve conduction studies (NCS) have been adopted as a routine part of the diagnostic process. In the United Kingdom, the time taken to access diagnostic tests has been likened to a “hidden waiting list”, lengthening the time taken for a patient to access treatment. In the current healthcare climate with a centrally driven aim to reduce patient waiting time to a maximum of eighteen weeks, including tests, such waiting is even more unacceptable. Aim. This study was performed in order to evaluate a simple handheld device for quantifying median nerve lesions in CTS. Design of study: A prospective blinded cohort study. Setting: Leicester General Hospital, Carpal Tunnel Service Method: Participants were recruited from the nor-mal referral stream. If the clinical findings were consistent with a diagnosis of CTS, they were for-mally consented to the study in which results from the new handheld device were compared with traditional NCS. Final test group consisted of 63 participants. Results: For the new device the correct positive detection rate for abnormal nerve conduction was 91% (74/81 hands). Of the seven abnormal results not picked up by the new device, four were in asymptomatic hands (positive per cent agree-ment in symptomatic hands 95%). There were no false positives with the new system. (Negative per cent agreement 100%) Conclusion: We conclude that this new device demonstrates a high degree of concordance with currently available traditional NCS. The study suggested ways in which the accuracy could be further improved. Background: Carpal Tunnel Syndrome (CTS) is the commonest upper limb nerve entrapment syndrome seen in practice. In many centres, nerve conduction studies (NCS) have been adopted as a routine part of the diagnostic process. In the United Kingdom, the time taken to access diagnostic tests has been likened to a “hidden waiting list”, lengthening the time taken for a patient to access treatment. In the current healthcare climate with a centrally driven aim to reduce patient waiting time to a maximum of eighteen weeks, including tests, such waiting is even more unacceptable. Aim. This study was performed in order to evaluate a simple handheld device for quantifying median nerve lesions in CTS. Design of study: A prospective blinded cohort study. Setting: Leicester General Hospital, Carpal Tunnel Service Method: Participants were recruited from the nor-mal referral stream. If the clinical findings were consistent with a diagnosis of CTS, they were for-mally consented to the study in which results from the new handheld device were compared with traditional NCS. Final test group consisted of 63 participants. Results: For the new device the correct positive detection rate for abnormal nerve conduction was 91% (74/81 hands). Of the seven abnormal results not picked up by the new device, four were in asymptomatic hands (positive per cent agree-ment in symptomatic hands 95%). There were no false positives with the new system. (Negative per cent agreement 100%) Conclusion: We conclude that this new device demonstrates a high degree of concordance with currently available traditional NCS. The study suggested ways in which the accuracy could be further improved.
机构地区 不详
出处 《Journal of Biomedical Science and Engineering》 2011年第4期282-288,共7页 生物医学工程(英文)
关键词 CARPAL TUNNEL SYNDROME NERVE Conduction Studies Diagnosis PORTABLE Carpal Tunnel Syndrome Nerve Conduction Studies Diagnosis Portable
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部